Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. The company is headquartered in Redwood City, California and currently employs 46 full-time employees. The company went IPO on 2015-10-26. The firm developed its Bioflux COM technology, comprised of a monitoring device and software components. Its Bioflux and Biocore Pro are integrated electrocardiogram (ECG) device and software solutions for the COM market. The Biocore ECG reporting software allows doctors and labs to view a patient’s ECG data for monitoring and diagnostic purposes. The Bioflux and Biocore Pro platform has a built-in cellular chipset and a real-time embedded operating system which allows its technology to be utilized as an Internet of Things (IoT) platform. The firm has developed several technologies, including Bioheart, Biocare, and Biokit. Biokit is a remote patient monitoring kit that combines a blood pressure cuff, pulse oximeter and a digital thermometer into the Biocare platform to support the collection of additional biometrics for those patients with multiple conditions.
Mr. Waqaas Al-Siddiq es el Chairman of the Board de Biotricity Inc, se unió a la empresa desde 2016.
¿Qué tal es el rendimiento del precio de la acción BTCY?
El precio actual de BTCY es de $0.2499, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Biotricity Inc?
Biotricity Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Biotricity Inc?
La capitalización bursátil actual de Biotricity Inc es $6.9M
¿Es Biotricity Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Biotricity Inc, incluyendo 0 fuerte compra, 0 compra, 3 mantener, 1 venta, y 0 fuerte venta